Andersen M, Andresen AK, Hartvigsen J, Hermann AP, Sørensen J, Carreon LY. Vertebroplasty for painful osteoporotic vertebral compression fractures: a protocol for a single-center doubled-blind randomized sham-controlled clinical trial. VOPE2. J Orthop Surg Res. 2024;19(1):813.
Article PubMed PubMed Central Google Scholar
Shen L, Yang H, Zhou F, Jiang T, Jiang Z. Risk factors of short-term residual low back pain after PKP for the first thoracolumbar osteoporotic vertebral compression fracture. J Orthop Surg Res. 2024;19(1):792.
Article PubMed PubMed Central Google Scholar
Leeyaphan J, Rojjananukulpong K, Intarasompun P, Peerakul Y. Simple clinical predictors for making directive decisions in osteoporosis screening for women: a cross-sectional study. J Orthop Surg Res. 2024;19(1):789.
Article PubMed PubMed Central Google Scholar
Misra S, Bagchi A, Sarkar A, Niyogi S, Bhattacharjee D, Chatterjee S, Mondal S, Chattopadhyay A, Saha A, Chatterjee S, et al. Methotrexate and theaflavin-3, 3’-digallate synergistically restore the balance between apoptosis and autophagy in synovial fibroblast of RA: an ex vivo approach with cultured human RA FLS. Inflammopharmacology. 2021;29(5):1427–42.
Article CAS PubMed Google Scholar
Oray M, Abu Samra K, Ebrahimiadib N, Meese H, Foster CS. Long-term side effects of glucocorticoids. Exp Opin Drug Saf. 2016;15(4):457–65.
Migliorini F, Giorgino R, Hildebrand F, Spiezia F, Peretti GM, Alessandri-Bonetti M, Eschweiler J, Maffulli N. Fragility fractures: risk factors and management in the elderly. Med (Kaunas Lithuania). 2021;57(10):1119.
Migliorini F, Colarossi G, Eschweiler J, Oliva F, Driessen A, Maffulli N. Antiresorptive treatments for corticosteroid-induced osteoporosis: a bayesian network meta-analysis. Br Med Bull. 2022;143(1):46–56.
Article CAS PubMed PubMed Central Google Scholar
Conti V, Russomanno G, Corbi G, Toro G, Simeon V, Filippelli W, Ferrara N, Grimaldi M, D’Argenio V, Maffulli N, et al. A polymorphism at the translation start site of the vitamin D receptor gene is associated with the response to anti-osteoporotic therapy in postmenopausal women from Southern Italy. Int J Mol Sci. 2015;16(3):5452–66.
Article CAS PubMed PubMed Central Google Scholar
Migliorini F, Maffulli N, Colarossi G, Eschweiler J, Tingart M, Betsch M. Effect of drugs on bone mineral density in postmenopausal osteoporosis: a bayesian network meta-analysis. J Orthop Surg Res. 2021;16(1):533.
Article PubMed PubMed Central Google Scholar
Bao X, Liu C, Liu H, Wang Y, Xue P, Li Y. Association between polymorphisms of glucagon-like peptide-1 receptor gene and susceptibility to osteoporosis in Chinese postmenopausal women. J Orthop Surg Res. 2024;19(1):869.
Article PubMed PubMed Central Google Scholar
Migliorini F, Colarossi G, Baroncini A, Eschweiler J, Tingart M, Maffulli N. Pharmacological management of postmenopausal osteoporosis: a level I evidence Based - Expert opinion. Expert Rev Clin Pharmacol. 2021;14(1):105–19.
Article CAS PubMed Google Scholar
Lei C, Song JH, Li S, Zhu YN, Liu MY, Wan MC, Mu Z, Tay FR, Niu LN. Advances in materials-based therapeutic strategies against osteoporosis. Biomaterials. 2023;296:122066.
Article CAS PubMed Google Scholar
Chen Z, Xue J, Shen T, Mu S, Fu Q. Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway. Int J Mol Med. 2016;37(2):329–38.
Zhao Y, Wang HL, Li TT, Yang F, Tzeng CM. Baicalin Ameliorates Dexamethasone-Induced Osteoporosis by Regulation of the RANK/RANKL/OPG Signaling Pathway. Drug design, development and therapy. 2020;14:195–206.
Xie B, Wu J, Li Y, Wu X, Zeng Z, Zhou C, Xu D, Wu L. Geniposide alleviates Glucocorticoid-Induced Inhibition of osteogenic differentiation in MC3T3-E1 cells by ERK pathway. Front Pharmacol. 2019;10:411.
Article CAS PubMed PubMed Central Google Scholar
Huang F, Wang Y, Liu J, Cheng Y, Zhang X, Jiang H. Asperuloside alleviates osteoporosis by promoting autophagy and regulating Nrf2 activation. J Orthop Surg Res. 2024;19(1):855.
Article PubMed PubMed Central Google Scholar
Onozato T, Nakamura CV, Cortez DA, Dias Filho BP, Ueda-Nakamura T. Tanacetum vulgare: antiherpes virus activity of crude extract and the purified compound parthenolide. Phytother Res. 2009;23(6):791–6.
Article CAS PubMed Google Scholar
Freund RRA, Gobrecht P, Fischer D, Arndt HD. Advances in chemistry and bioactivity of parthenolide. Nat Prod Rep. 2020;37(4):541–65.
Article CAS PubMed Google Scholar
Sztiller-Sikorska M, Czyz M. Parthenolide as cooperating agent for Anti-Cancer treatment of various malignancies. Pharmaceuticals (Basel Switzerland). 2020;13(8):194.
Materazzi S, Benemei S, Fusi C, Gualdani R, De Siena G, Vastani N, Andersson DA, Trevisan G, Moncelli MR, Wei X, et al. Parthenolide inhibits nociception and neurogenic vasodilatation in the trigeminovascular system by targeting the TRPA1 channel. Pain. 2013;154(12):2750–58.
Article CAS PubMed Google Scholar
Zhang Y, Huang Q, Chen Y, Peng X, Wang Y, Li S, Wu J, Luo C, Gong W, Yin B, et al. Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway. Int Immunopharmacol. 2020;78:106064.
Article CAS PubMed Google Scholar
Wang JA, Tong ML, Zhao B, Zhu G, Xi DH, Yang JP. Parthenolide ameliorates intracerebral hemorrhage-induced brain injury in rats. Phytother Res. 2020;34(1):153–60.
Article CAS PubMed Google Scholar
Liu YJ, Tang B, Wang FC, Tang L, Lei YY, Luo Y, Huang SJ, Yang M, Wu LY, Wang W, et al. Parthenolide ameliorates colon inflammation through regulating Treg/Th17 balance in a gut microbiota-dependent manner. Theranostics. 2020;10(12):5225–41.
Article CAS PubMed PubMed Central Google Scholar
Ding W, Cai C, Zhu X, Wang J, Jiang Q. Parthenolide ameliorates neurological deficits and neuroinflammation in mice with traumatic brain injury by suppressing STAT3/NF-κB and inflammasome activation. Int Immunopharmacol. 2022;108:108913.
Article CAS PubMed Google Scholar
Skoumal R, Tóth M, Serpi R, Rysä J, Leskinen H, Ulvila J, Saiho T, Aro J, Ruskoaho H, Szokodi I, et al. Parthenolide inhibits STAT3 signaling and attenuates angiotensin II-induced left ventricular hypertrophy via modulation of fibroblast activity. J Mol Cell Cardiol. 2011;50(4):634–41.
Article CAS PubMed Google Scholar
Idris AI, Krishnan M, Simic P, Landao-Bassonga E, Mollat P, Vukicevic S, Ralston SH. Small molecule inhibitors of IkappaB kinase signaling inhibit osteoclast formation in vitro and prevent ovariectomy-induced bone loss in vivo. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 2010;24(11):4545–55.
Kim JY, Cheon YH, Yoon KH, Lee MS, Oh J. Parthenolide inhibits osteoclast differentiation and bone resorbing activity by down-regulation of NFATc1 induction and c-Fos stability, during RANKL-mediated osteoclastogenesis. BMB Rep. 2014;47(8):451–6.
Article PubMed PubMed Central Google Scholar
Zhang X, Chen Q, Liu J, Fan C, Wei Q, Chen Z, Mao X. Parthenolide promotes differentiation of osteoblasts through the Wnt/β-Catenin signaling pathway in inflammatory environments. J Interferon Cytokine Research: Official J Int Soc Interferon Cytokine Res. 2017;37(9):406–14.
Liu Q, Zhao J, Tan R, Zhou H, Lin Z, Zheng M, Romas E, Xu J, Sims NA. Parthenolide inhibits pro-inflammatory cytokine production and exhibits protective effects on progression of collagen-induced arthritis in a rat model. Scand J Rheumatol. 2015;44(3):182–91.
Williams B, Lees F, Tsangari H, Hutchinson MR, Perilli E, Crotti TN. Assessing the effects of parthenolide on inflammation, bone loss, and glial cells within a collagen Antibody-Induced arthritis mouse model. Mediat Inflamm. 2020;2020:6245798.
Zawawi MS, Marino V, Perilli E, Cantley MD, Xu J, Purdue PE, Dharmapatni AA, Haynes DR, Crotti TN. Parthenolide reduces empty lacunae and osteoclastic bone surface resorption induced by polyethylene particles in a murine calvarial model of peri-implant osteolysis. J Biomedical Mater Res Part A. 2015;103(11):3572–9.
Mao W, Zhu Z. Parthenolide inhibits hydrogen peroxide–induced osteoblast apoptosis. Mol Med Rep. 2018;17(6):8369–76.
Comments (0)